BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8146197)

  • 21. Phosphatidylinositol 4-Phosphate 5-Kinases in the Regulation of T Cell Activation.
    Porciello N; Kunkl M; Viola A; Tuosto L
    Front Immunol; 2016; 7():186. PubMed ID: 27242793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD28 Costimulation: From Mechanism to Therapy.
    Esensten JH; Helou YA; Chopra G; Weiss A; Bluestone JA
    Immunity; 2016 May; 44(5):973-88. PubMed ID: 27192564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycogen Synthase Kinase 3 Inactivation Drives T-bet-Mediated Downregulation of Co-receptor PD-1 to Enhance CD8(+) Cytolytic T Cell Responses.
    Taylor A; Harker JA; Chanthong K; Stevenson PG; Zuniga EI; Rudd CE
    Immunity; 2016 Feb; 44(2):274-86. PubMed ID: 26885856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-150 impairs inflammatory cytokine production by targeting ARRB-2 after blocking CD28/B7 costimulatory pathway.
    Sang W; Wang Y; Zhang C; Zhang D; Sun C; Niu M; Zhang Z; Wei X; Pan B; Chen W; Yan D; Zeng L; Loughran TP; Xu K
    Immunol Lett; 2016 Apr; 172():1-10. PubMed ID: 26549736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A highly recurrent novel missense mutation in CD28 among angioimmunoblastic T-cell lymphoma patients.
    Lee SH; Kim JS; Kim J; Kim SJ; Kim WS; Lee S; Ko YH; Yoo HY
    Haematologica; 2015 Dec; 100(12):e505-7. PubMed ID: 26405154
    [No Abstract]   [Full Text] [Related]  

  • 26. Vav1 Regulates T-Cell Activation through a Feedback Mechanism and Crosstalk between the T-Cell Receptor and CD28.
    Helou YA; Petrashen AP; Salomon AR
    J Proteome Res; 2015 Jul; 14(7):2963-75. PubMed ID: 26043137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B7-H5 costimulates human T cells via CD28H.
    Zhu Y; Yao S; Iliopoulou BP; Han X; Augustine MM; Xu H; Phennicie RT; Flies SJ; Broadwater M; Ruff W; Taube JM; Zheng L; Luo L; Zhu G; Chen J; Chen L
    Nat Commun; 2013; 4():2043. PubMed ID: 23784006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic motile T cells highly respond to the T cell stimulation via PI3K-Akt and NF-κB pathways.
    Kim HR; Na BR; Kwon MS; Ko YS; Han WC; Jun CD
    PLoS One; 2013; 8(3):e59793. PubMed ID: 23555783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein kinase C signaling and cell cycle regulation.
    Black AR; Black JD
    Front Immunol; 2012; 3():423. PubMed ID: 23335926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Murine regulatory T cells differ from conventional T cells in resisting the CTLA-4 reversal of TCR stop-signal.
    Lu Y; Schneider H; Rudd CE
    Blood; 2012 Nov; 120(23):4560-70. PubMed ID: 23047820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PKC-theta-mediated signal delivery from the TCR/CD28 surface receptors.
    Isakov N; Altman A
    Front Immunol; 2012; 3():273. PubMed ID: 22936936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Staying alive: metabolic adaptations to quiescence.
    Valcourt JR; Lemons JM; Haley EM; Kojima M; Demuren OO; Coller HA
    Cell Cycle; 2012 May; 11(9):1680-96. PubMed ID: 22510571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence implicating the Ras pathway in multiple CD28 costimulatory functions in CD4+ T cells.
    Janardhan SV; Praveen K; Marks R; Gajewski TF
    PLoS One; 2011; 6(9):e24931. PubMed ID: 21949793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B7-h2 is a costimulatory ligand for CD28 in human.
    Yao S; Zhu Y; Zhu G; Augustine M; Zheng L; Goode DJ; Broadwater M; Ruff W; Flies S; Xu H; Flies D; Luo L; Wang S; Chen L
    Immunity; 2011 May; 34(5):729-40. PubMed ID: 21530327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD28 co-signaling in the adaptive immune response.
    Riha P; Rudd CE
    Self Nonself; 2010 Jul; 1(3):231-240. PubMed ID: 21487479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biased binding of class IA phosphatidyl inositol 3-kinase subunits to inducible costimulator (CD278).
    Acosta YY; Zafra MP; Ojeda G; Bernardone IS; Dianzani U; Portolés P; Rojo JM
    Cell Mol Life Sci; 2011 Sep; 68(18):3065-79. PubMed ID: 21188463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rigid-body ligand recognition drives cytotoxic T-lymphocyte antigen 4 (CTLA-4) receptor triggering.
    Yu C; Sonnen AF; George R; Dessailly BH; Stagg LJ; Evans EJ; Orengo CA; Stuart DI; Ladbury JE; Ikemizu S; Gilbert RJ; Davis SJ
    J Biol Chem; 2011 Feb; 286(8):6685-96. PubMed ID: 21156796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycogen synthase kinase 3: a point of convergence for the host inflammatory response.
    Wang H; Brown J; Martin M
    Cytokine; 2011 Feb; 53(2):130-40. PubMed ID: 21095632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An enigmatic tail of CD28 signaling.
    Boomer JS; Green JM
    Cold Spring Harb Perspect Biol; 2010 Aug; 2(8):a002436. PubMed ID: 20534709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross talk between phosphatidylinositol 3-kinase and cyclic AMP (cAMP)-protein kinase a signaling pathways at the level of a protein kinase B/beta-arrestin/cAMP phosphodiesterase 4 complex.
    Bjørgo E; Solheim SA; Abrahamsen H; Baillie GS; Brown KM; Berge T; Okkenhaug K; Houslay MD; Taskén K
    Mol Cell Biol; 2010 Apr; 30(7):1660-72. PubMed ID: 20086095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.